Costacurta, M., Vervoort, S. J., Hogg, S. J., Martin, B. P., Johnstone, R. W. and Shortt, J. (2021) “Whole genome CRISPR screening identifies TOP2B as a potential target for IMiD sensitization in multiple myeloma”, Haematologica. Pavia, Italy, 106(7), pp. 2013-2017. doi: 10.3324/haematol.2020.265611.